Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Tecnotree Corporation - Managers' transactions - Koskelainen

Tecnotree Corporation Stock Exchange Release 1 September 2023 at 12:00 EESTPerson subject to the notification requirementName: Koskelainen, LeenaPosition: Other senior managerIssuer: Tecnotree CorporationLEI: 743700MRPVYI7ASHCX38 Notification type: INITIAL NOTIFICATIONReference number: 743700MRPVYI7ASHCX38_20230901084638_565____________________________________________ Transaction date: 2023-08-31Venue not applicableInstrument type: SHAREISIN: FI0009010227Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 17290 Unit

Paindrainer® secures certification by ORCHA – the world’s leading digital health evaluation organization

LUND, SWEDEN – The company is pleased to announce that the Paindrainer® App has been certified by the Organization for the Review of Care and Health Apps (ORCHA). ORCHA is the world’s leading, independent digital health evaluation and distribution organization, providing verification and certification, which is trusted and accepted by health-care organizations internationally.ORCHA’s assessment involves a detailed analysis looking across all the key areas of regulation and compliance. Mobile health apps are assessed against 350 criteria covering 3 main domains: · Clinical assurance and

NOTICE OF FARON PHARMACEUTICALS LTD'S EXTRAORDINARY GENERAL MEETING

NOTICE OF faron pharmaceuticals LTD’s extraordinary GENERAL MEETING Shareholders of Faron Pharmaceuticals Ltd (the “Company”) are notified of the Extraordinary General Meeting to be held on September 22, 2023 at 9:00 a.m. EEST (Finnish time) at BioCity, meeting room “Ministeri” at Tykistökatu 6, FI-20520 Turku, Finland. The registration of attendees and the distribution of voting slips will commence at the meeting venue at 8:30 a.m. EEST (Finnish time). The Board of Directors of the Company (the “Board”) has resolved to convene the Extraordinary General Meeting to resolve on the

Nomination Committe proposes new Chariman in Dustin

The Nomination Committee of Dustin has decided to propose that Thomas Ekman shall be elected as Chariman of the Board at the Annual General Meeting on December 12. Mia Brunell Livfors has announced that she is not available for re-election as Chairman of the Board, but as member of the board.- We are very pleased to be able to propose Thomas Ekman as the new Chairman of the Board. With his solid knowledge of the company, he will ensure continued continuity. We also want to thank Mia Brunell Livfors for her valuable contribution as Chairman of the Board and we appreciate that she wants to

Leslie McDonnell joins Mölnlycke’s Board of Directors

Leslie McDonnell has been elected Member of Mölnlycke AB’s Board of Directors on 1 September 2023.Leslie McDonnell has more than 20 years of experience in the Medtech industry through executive leadership roles at Medtronic, 3M Healthcare, and Natus Medical. Most recently, Leslie was President, CEO and Board Member of Iradimed Corporation and currently serves on the Board of Directors at Laborie Medical Technologies. She brings deep cross-functional and management experience across a range of technology platforms and clinical areas. “I am pleased to welcome Leslie as a Member of the

Tecnotree Corporation - Managers' transactions - Ketkar

Tecnotree Corporation Stock Exchange Release 1 September 2023 at 12:00 EESTPerson subject to the notification requirementName: Ketkar, SanjayPosition: Other senior managerIssuer: Tecnotree CorporationLEI: 743700MRPVYI7ASHCX38 Notification type: INITIAL NOTIFICATIONReference number: 743700MRPVYI7ASHCX38_20230901084638_564____________________________________________ Transaction date: 2023-08-31Venue not applicableInstrument type: SHAREISIN: FI0009010227Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 13510 Unit price:

Tecnotree Corporation - Managers' transactions - Naliyamanda Krishna

Tecnotree Corporation Stock Exchange Release 1 September 2023 at 12:00 EESTPerson subject to the notification requirementName: Naliyamanda Krishna, SavithaPosition: Other senior managerIssuer: Tecnotree CorporationLEI: 743700MRPVYI7ASHCX38 Notification type: INITIAL NOTIFICATIONReference number: 743700MRPVYI7ASHCX38_20230901084638_562____________________________________________ Transaction date: 2023-08-31Venue not applicableInstrument type: SHAREISIN: FI0009010227Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume:

Tecnotree Corporation - Managers' transactions - Ravichander

Tecnotree Corporation Stock Exchange Release 1 September 2023 at 12:00 EESTPerson subject to the notification requirementName: Ravichander, PadmaPosition: Chief Executive OfficerIssuer: Tecnotree CorporationLEI: 743700MRPVYI7ASHCX38 Notification type: INITIAL NOTIFICATIONReference number: 743700MRPVYI7ASHCX38_20230901084638_559____________________________________________ Transaction date: 2023-08-31Venue not applicableInstrument type: SHAREISIN: FI0009010227Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 445686

Tecnotree Corporation - Managers' transactions - Subramanian

Tecnotree Corporation Stock Exchange Release 1 September 2023 at 12:00 EESTPerson subject to the notification requirementName: Subramanian, RamaseshanPosition: Other senior managerIssuer: Tecnotree CorporationLEI: 743700MRPVYI7ASHCX38 Notification type: INITIAL NOTIFICATIONReference number: 743700MRPVYI7ASHCX38_20230901084638_563____________________________________________ Transaction date: 2023-08-31Venue not applicableInstrument type: SHAREISIN: FI0009010227Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 21999

Tecnotree Corporation - Managers' transactions - Thomas

Tecnotree Corporation Stock Exchange Release 1 September 2023 at 12:00 EESTPerson subject to the notification requirementName: Thomas, SajanPosition: Other senior managerIssuer: Tecnotree CorporationLEI: 743700MRPVYI7ASHCX38 Notification type: INITIAL NOTIFICATIONReference number: 743700MRPVYI7ASHCX38_20230901084638_560____________________________________________ Transaction date: 2023-08-31Venue not applicableInstrument type: SHAREISIN: FI0009010227Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 41790 Unit price:

Tecnotree Corporation - Managers' transactions - Vivekananda

Tecnotree Corporation Stock Exchange Release 1 September 2023 at 12:00 EESTPerson subject to the notification requirementName: Vivekananda, IndireshPosition: Chief Financial OfficerIssuer: Tecnotree CorporationLEI: 743700MRPVYI7ASHCX38 Notification type: INITIAL NOTIFICATIONReference number: 743700MRPVYI7ASHCX38_20230901084638_566____________________________________________ Transaction date: 2023-08-31Venue not applicableInstrument type: SHAREISIN: FI0009010227Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 66667

Zerion Pharma A/S appoints Mads Aaboe Jensen as Vice President, Business Development

September 1, 2023 (COPENHAGEN, Denmark). Zerion Pharma A/S (“ZERION”) today announces that the Company has strengthened its management team with the appointment of Dr. Mads Aaboe Jensen as Vice President Business Development. Mads Aaboe joins ZERION from September 1.Mads Aaboe will be responsible for the Company’s business development and commercial activities relating to ZERION’s Dispersome® technology that has proven to be very efficient in improving the solubility and bioavailability of small molecule drugs. ZERION has established partnerships with a significant number of large

Realheart selected for Business Sweden’s Catalyst programme

Press release 2023-09-01 Scandinavian Real Heart AB has been selected for Business Sweden's scale-up programme Catalyst, which aims to create international growth. In the program targeting Sweden’s most innovative and promising companies, participants receive a customized project plan for market entry valued at 250,000 SEK and opportunities to build network in the market, among investors and other experts.- Scandinavian Real Heart is one of Sweden’s most exciting and innovative medtech companies. With Scandinavian Real Heart, Sweden has the opportunity to develop into a leading Life

BioStock: Lipum reports Q2 and increases the pace

In the report for the second quarter, biopharmaceutical company Lipum announces that they are increasing the pace of development of SOL-116 for rheumatoid arthritis. The clinical phase I study with the candidate is progressing according to plan and the company has identified a possibility to accelerate the second part of the study. With financial resources in place, the company looks forward to reporting results from the study in early 2024.Read the full article at biostock.se: https://www.biostock.se/en/2023/09/lipum-reports-q2-and-increases-the-pace/ This is a press release from

Hemsö’s shareholders make an equity injection of SEK 1.0 billion

Hemsö’s shareholders have decided to make an equity injection of SEK 1.0 billion to strengthen the capital structure and to finance Hemsö’s investments in new sustainable schools and nursing homes. The capital will be injected during the third quarter of 2023.“A stronger capital structure and liquidity position enables Hemsö to continue to support the public sector in times of growing need for new social infrastructure. With this year’s capital injection Hemsö’s owners have since 2019 provided equity of SEK 4.0 billion which has enabled investments in mainly new development of schools and

Case Study Snippets

Fenris the Cocker Spaniel defies death after licking jellyfish Swift vet action saved the day as UK family warns other pet owners about beach safety.   During a stroll in Colwyn Bay, Fenris the 11-month-old Cocker Spaniel encountered a Lion's Mane jellyfish. The happy-go-lucky pup licked the jellyfish, immediately causing vomiting and distress. In a  desperate state, Fenris ingested sand and sea water.   Recognising the urgency, her owner rushed her to a nearby weekend vet. Acting swiftly, the vet administered antihistamines and opioids to counter venom effects. A 20-minute

Love for Luna – Top Puppy Names by Breed!

Agria Pet Insurance reveals the 2023 puppy names that have taken the UK by storm.Finding the perfect name for your puppy can be an exciting but tough task. Whether you're drawn to a sentimental name or want to pick the cutest name for your adorable pooch, it's helpful to know the trendiest names for your furry companion. Keep in mind that these popular names can evolve over time, so it's vital to stay in the loop!   Luna reigned supreme as the top name amongst the majority of dog breeds, closely followed by Teddy and Poppy.   One of the world’s leading animal insurers - Agria

Arctic Paper moves to Warsaw Stock Exchange mWIG40 index

Arctic Paper S.A. announces that from September 1, 2023, the company's shares will be traded on Warsaw Stock Exchange mWIG40 index. mWIG40 index is successor of MIDWIG index and has been calculated since December 31, 1997 and comprises 40 medium size companies listed at WSE Main List. mWIG40 is a price index and thus when it is calculated it accounts only for prices of underlying shares whereas dividend income is excluded."The move of our stock to the mWIG40 index confirms that the course of development of Arctic Paper is correct. It is also a proof that our position on the capital market

BioStock: BioInvent soon has five drug candidates in six clinical studies

BioInvent has made several advances in the second quarter of 2023, in particular with its lead drug candidate BI-1206. In addition to a strengthened pipeline, the company’s Q2 report highlights progress across the broad portfolio of drug candidates in clinical development. In the report, CEO Martin Welschof reminds that BioInvent will soon have five drug candidates in six parallel patient studies.Read the article at biostock.se: https://www.biostock.se/en/2023/09/bioinvent-soon-has-five-drug-candidates-in-six-clinical-studies/ This is a press release from BioStock - Connecting

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 131 - 1 SEPTEMBER 2023   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 112/23 and 113/23.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Contract extension for CSV “Normand Superior”

Solstad Offshore is pleased to announce a contract extension for the CSV “Normand Superior” with Ocean Infinity AB. The contract is now firm until 1Q 2026, with two optional years thereafter. The commercial terms are in line with present market conditions for this type of vessel.  Skudeneshavn, 1st September 2023 ContactsLars Peder Solstad CEO, at +47 91 31 85 85Kjetil Ramstad CFO, at +47 90 75 94 89 Solstad Offshore ASA

SBTi approves Sandvik’s science-based emission reduction targets

Sandvik’s targets for reducing greenhouse gas (GHG) emissions have now been validated by the Science Based Targets initiative (SBTi) as aligned with the latest climate science and consistent with the goals of the Paris Agreement. Sandvik committed to set targets in line with SBTI’s criteria in December 2021 and submitted the new targets for validation in November 2022. With the new targets Sandvik commits to reach net-zero GHG emissions by 2050 at the latest. Sandvik also commits to reducing absolute scope 1 and 2 GHG emissions by 50% by 2030 with 2019 as the base year, and to reduce

Medivir Hosts Expert Perspectives Webcast on the Evolving Treatment Landscape and the Unique Treatment Challenges in HCC

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that it will host a key opinion leader webcast on the current and future HCC (primary liver cancer) treatment landscape, including how treatment challenges and needs in HCC differs from most other cancers. The webcast will take place on September 8, 2023 at 13:00 CET/07:00 EST. The webcast will feature presentations by Dr. Jeff Evans, Beatson West of Scotland Cancer Center, Glasgow, UK, who will

TARJA MYLÉN APPOINTED AS MANDATUM’S CHIEF AUDIT EXECUTIVE

Tarja Mylén has been appointed as Mandatum’s Chief Audit Executive, having previously acted in numerous positions over a long period of time within Sampo Group. Internal Audit is carried out independently of the company’s business operations. Its mandate is to objectively assess and ensure the organisation’s business activities. Mylén joins Mandatum from the position of Responsible Internal Auditor at Sampo Group. She began her career in Sampo in 1986 and moved to Internal Audit in 2001 after working with business operations for 15 years. Mylén has also acted as Chief Audit Executive for

There are no items matching the current filter
There are no more items matching the current filter
Back to top